Dr. Kathryn DinhMD

Endocrinology

at River City Endocrine PLLC — Hixson, TN

About

Dr. Kathryn Dinh graduated with honors from Harvard Medical School and completed both her internal medicine residency and her fellowship in Endocrinology, Diabetes, and Metabolism at the University of Washington in Seattle. During medical school, she spent a year researching the impact of hormonal therapy on prostate cancer patients, producing several first-author publications. The University of Washington runs a premier pituitary program, and that training gave Dr. Dinh deep experience managing pituitary adenomas, hypopituitarism, and prolactin elevations. She holds double board certification in Internal Medicine (2019) and Endocrinology, Diabetes, and Metabolism (2021).

Dr. Dinh treats the full range of endocrine conditions, with particular focus on diabetes, thyroid cancer, thyroid disorders, adrenal disease, metabolic syndrome, osteoporosis, and complex pituitary conditions. She has treated rare bone diseases including osteogenesis imperfecta and hypophosphatemia, and she has managed complex Cushing's disease cases using Osilodrostat. Dr. Dinh screens all patients with diabetes, insulin resistance, or obesity for liver disease using the FIB-4 Index and fibroscan when indicated. She believes medicine begins with listening. Her philosophy centers on building a relationship first, then developing a detailed, patient-centered plan. Originally from Evansville, Indiana, she has made Chattanooga home since 2021. She is married with two children and enjoys cooking, reading, coffee, and time with family and friends.

Education & Training

Medical School

Harvard Medical School, Graduated with Honors, Boston, MA

Residency

Internal Medicine, University of Washington, Seattle, WA

Fellowship

Endocrinology, Diabetes and Metabolism, University of Washington, Seattle, WA

Additional Training

Year of research on prostate cancer during medical school, including impact of hormonal therapy on patients, resulting in several first-author publications

Certifications

American Board of Internal Medicine, 2019Endocrinology, Diabetes, and Metabolism, 2021

Conditions Treated

diabetes (Type 1, Type 2, pancreatic, steroid-associated, immunotherapy-induced, atypical)thyroid cancer (papillary, follicular, medullary)hypothyroidismhyperthyroidismHashimoto's diseaseGraves' diseasethyroid nodulesmetabolic syndromeobesityosteoporosisosteogenesis imperfectahypophosphatemiaadrenal insufficiencyCushing's diseaseadrenal noduleshyperparathyroidismhypoparathyroidismpituitary adenomashyperprolactinemiaPCOSmale hypogonadismprimary ovarian insufficiencysymptomatic menopauselipid disordersMASLDMASH

Who is Dr. Dinh right for?

Dr. Dinh is a strong fit for adults managing complex or difficult-to-control endocrine conditions. Patients with any type of diabetes, thyroid cancer, or thyroid disorders benefit directly from her clinical depth. She also serves adults dealing with adrenal disease, pituitary dysfunction, PCOS, hypogonadism, osteoporosis, or metabolic syndrome. Patients who want thorough, evidence-based evaluations and longer visits will find her approach well-suited to their needs.

Similar Doctors Nearby

Frequently Asked Questions

Dr. Dinh treats the full spectrum of endocrine disorders. Her clinical focus includes all types of diabetes, thyroid cancer, hypothyroidism, hyperthyroidism, Hashimoto's disease, Graves' disease, adrenal disease, Cushing's disease, pituitary adenomas, PCOS, male hypogonadism, osteoporosis, hyperparathyroidism, metabolic syndrome, and obesity. She also manages MASLD and MASH in patients with metabolic risk factors.

Yes, Dr. Dinh holds double board certification. She is board certified in Internal Medicine (2019) and in Endocrinology, Diabetes, and Metabolism (2021), both through the American Board of Internal Medicine.

Dr. Dinh graduated with honors from Harvard Medical School. She completed her internal medicine residency and her endocrinology fellowship at the University of Washington in Seattle, which is home to a nationally recognized pituitary program.

Yes. Dr. Dinh has treated complex Cushing's disease using Osilodrostat and rare bone diseases including osteogenesis imperfecta and hypophosphatemia. Her fellowship at the University of Washington gave her substantial experience with pituitary adenomas, pituitary excess and deficiency, and hyperprolactinemia.

Dr. Dinh manages all forms of diabetes, including Type 1, Type 2, pancreatic, steroid-associated, immunotherapy-induced, and atypical diabetes. She incorporates continuous glucose monitors and insulin pumps into her care plans. Membership includes complimentary CGM placement, training, and device downloads at each visit.

Yes. Dr. Dinh manages papillary, follicular, and medullary thyroid cancer. She has built working relationships with head and neck surgeons in the Chattanooga area to coordinate surgical planning, radioactive iodine preparation, and ongoing surveillance. She individualizes monitoring and treatment goals for each patient.

Dr. Dinh takes a targeted, evidence-based approach to hormone testing. She orders tests based on a patient's specific clinical presentation and does not order comprehensive hormone panels or tests that do not match symptoms. This approach reduces the risk of false positives, unnecessary follow-up testing, and inappropriate treatment.

Dr. Dinh screens and manages metabolic-associated liver disease, specifically MASLD and MASH, in patients with diabetes, insulin resistance, or obesity. She uses the FIB-4 Index score for initial assessment and orders a fibroscan when she suspects moderate to advanced liver disease.

Dr. Dinh sees patients 18 and older. She considers patients aged 16 to 17 on a case-by-case basis, provided the concern is not related to puberty or growth disorders.

Yes. Dr. Dinh coordinates care with head and neck surgeons, neurosurgeons, radiation oncologists, and other specialists when patient needs require it. She works to ensure seamless communication across all providers involved in a patient's care.

Doctor profile last updated August 17, 2026